Fundamentals for N4 Pharma ( n4p )
Current Price: 0.01
Market Cap: 2.07m
Price / Net Assets: 0.99
Internal Rate of Return: -100%
PE10 Ratio: -1.63
Dividend Yield: 0%
Currency: £ GBP
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (m) | £0m | £0m | £0m | £0m | £0.07m | £0.11m | £0m | £0m | £0m | £2.26m | £0m |
| Revenue Growth | - | - | - | -100.00% | -36.36% | - | - | - | -100.00% | - | -26% |
| Profit / Loss | £-1.03m | £-1.54m | £-1.3m | £-0.88m | £-1.18m | £-1.84m | £-0.18m | £-1.05m | £-2.39m | £-0.16m | £-1m |
| Profit Increase/Decrease | -33.12% | 18.46% | 47.73% | -25.42% | -35.87% | 922.22% | -82.86% | -56.07% | 1,393.75% | - | 239% |
| Profit / Sales Ratio | - | - | - | - | - | - | - | - | - | - | 0% |
| Earnings per Share | £-0.01 | £-0.01 | £-0.01 | £-0.01 | £-0.01 | £-0.01 | £-0.08 | £-0.09 | £-0.01 | £0.00 | £-0.02 |
| Total Debt | £0.08m | £0.21m | £0.17m | £0.08m | £0.19m | £0.18m | £0.32m | £0.02m | £0.81m | £0.90m | £0.30m |
| Net Assets | £2.09m | £2.13m | £3.66m | £0.99m | £0.88m | £1.28m | £-0.28m | £0.64m | £1.04m | £3.45m | £1.59m |
| Debt / Asset Ratio | 3.69% | 8.97% | 4.44% | 7.48% | 17.76% | 12.33% | 800.00% | 3.03% | 43.78% | 20.69% | 20.69% |
| Dividend per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.00% |
| Dividend Cover | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0.00x |